Dexmedetomidine: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: [[Alpha-2 agonist]] | *Type: [[Alpha-2 agonist]]; [[Sedative agents]] | ||
*Dosage Forms:IV | *Dosage Forms:IV | ||
*Common Trade Names: Precedex (US), Dexdor (European) | *Common Trade Names: Precedex (US), Dexdor (European) | ||
| Line 45: | Line 42: | ||
*Provides analgesia and anesthesia | *Provides analgesia and anesthesia | ||
*Hemodynamically neutral medication | *Hemodynamically neutral medication | ||
*Provides sedation with maintenance of arousability, airway protection | |||
==See Also== | ==See Also== | ||
Revision as of 17:15, 19 June 2015
General
- Type: Alpha-2 agonist; Sedative agents
- Dosage Forms:IV
- Common Trade Names: Precedex (US), Dexdor (European)
Adult Dosing
- ICU Sedation: 1 mcg/kg over 10 minutes followed by 0.2 to 0.7 mcg/kg/hr
- Procedural Sedation: 1 mcg/kg over 10 minutes followed by 0.6 mcg/hr titrated to effect, generally 0.2 to 1 mcg/kg/hr
Pediatric Dosing
Special Populations
- Pregnancy Rating: C
- Lactation: Unknown if excreted in milk. Exercise caution
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hypotension
- Bradycardia
- Apnea
Common
- Hypotension
- Bradycardia
- Dry mouth
Pharmacology
- Half-life: 2 hours
- Metabolism: Hepatic
- Excretion: Renal
- Mechanism of Action: Selective alpha-2 agonist
Comments
- Provides analgesia and anesthesia
- Hemodynamically neutral medication
- Provides sedation with maintenance of arousability, airway protection